vs

Side-by-side financial comparison of Honest Company, Inc. (HNST) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $78.1M, roughly 1.8× Honest Company, Inc.). On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs -19.7%). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs -8.4%).

The Honest Company, Inc. is an American digital-first consumer goods company, based in Los Angeles and founded by actress Jessica Alba, Christopher Gavigan, and Brian Lee. The company had $319 million in 2021 sales, and was valued at roughly $550 million as of February 2022. Carla Vernón, Chief Executive Officer, is one of the first Afro-Latina CEOs of a U.S. publicly traded company. The Honest Company has raised multiple rounds of venture capital, and went public via an initial public offeri...

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

HNST vs TOI — Head-to-Head

Bigger by revenue
TOI
TOI
1.8× larger
TOI
$142.0M
$78.1M
HNST
Growing faster (revenue YoY)
TOI
TOI
+61.3% gap
TOI
41.6%
-19.7%
HNST
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
-8.4%
HNST

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
HNST
HNST
TOI
TOI
Revenue
$78.1M
$142.0M
Net Profit
$-7.5M
Gross Margin
42.6%
Operating Margin
56.6%
-4.9%
Net Margin
-5.3%
Revenue YoY
-19.7%
41.6%
Net Profit YoY
43.0%
EPS (diluted)
$0.00
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HNST
HNST
TOI
TOI
Q1 26
$78.1M
Q4 25
$88.0M
$142.0M
Q3 25
$92.6M
$136.6M
Q2 25
$93.5M
$119.8M
Q1 25
$97.3M
$104.4M
Q4 24
$99.8M
$100.3M
Q3 24
$99.2M
$99.9M
Q2 24
$93.0M
$98.6M
Net Profit
HNST
HNST
TOI
TOI
Q1 26
Q4 25
$-23.6M
$-7.5M
Q3 25
$758.0K
$-16.5M
Q2 25
$3.9M
$-17.0M
Q1 25
$3.3M
$-19.6M
Q4 24
$-809.0K
$-13.2M
Q3 24
$165.0K
$-16.1M
Q2 24
$-4.1M
$-15.5M
Gross Margin
HNST
HNST
TOI
TOI
Q1 26
42.6%
Q4 25
15.7%
Q3 25
37.3%
Q2 25
40.4%
Q1 25
38.7%
Q4 24
38.8%
Q3 24
38.7%
Q2 24
38.3%
Operating Margin
HNST
HNST
TOI
TOI
Q1 26
56.6%
Q4 25
-27.5%
-4.9%
Q3 25
0.3%
-5.9%
Q2 25
3.1%
-9.4%
Q1 25
2.6%
-9.5%
Q4 24
-1.0%
-11.9%
Q3 24
0.1%
-13.9%
Q2 24
-4.3%
-16.6%
Net Margin
HNST
HNST
TOI
TOI
Q1 26
Q4 25
-26.8%
-5.3%
Q3 25
0.8%
-12.1%
Q2 25
4.1%
-14.2%
Q1 25
3.3%
-18.8%
Q4 24
-0.8%
-13.1%
Q3 24
0.2%
-16.1%
Q2 24
-4.4%
-15.7%
EPS (diluted)
HNST
HNST
TOI
TOI
Q1 26
$0.00
Q4 25
$-0.21
$-0.04
Q3 25
$0.01
$-0.14
Q2 25
$0.03
$-0.15
Q1 25
$0.03
$-0.21
Q4 24
$-0.01
$-0.14
Q3 24
$0.00
$-0.18
Q2 24
$-0.04
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HNST
HNST
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$90.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$169.1M
$-15.7M
Total Assets
$214.9M
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HNST
HNST
TOI
TOI
Q1 26
$90.4M
Q4 25
$89.6M
Q3 25
$71.5M
Q2 25
$72.1M
Q1 25
$72.8M
Q4 24
$75.4M
Q3 24
$53.4M
Q2 24
$36.6M
$9.9M
Stockholders' Equity
HNST
HNST
TOI
TOI
Q1 26
$169.1M
Q4 25
$169.7M
$-15.7M
Q3 25
$190.2M
$-12.3M
Q2 25
$187.0M
$-9.0M
Q1 25
$180.4M
$5.1M
Q4 24
$174.3M
$3.6M
Q3 24
$133.9M
$15.5M
Q2 24
$129.7M
$29.2M
Total Assets
HNST
HNST
TOI
TOI
Q1 26
$214.9M
Q4 25
$225.4M
$164.7M
Q3 25
$241.5M
$163.6M
Q2 25
$249.0M
$159.8M
Q1 25
$265.3M
$164.0M
Q4 24
$247.4M
$172.7M
Q3 24
$209.2M
$179.2M
Q2 24
$200.2M
$179.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HNST
HNST
TOI
TOI
Operating Cash FlowLast quarter
$3.2M
Free Cash FlowOCF − Capex
$2.2M
FCF MarginFCF / Revenue
1.5%
Capex IntensityCapex / Revenue
0.6%
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HNST
HNST
TOI
TOI
Q1 26
Q4 25
$19.3M
$3.2M
Q3 25
$-504.0K
$-12.6M
Q2 25
$-745.0K
$-10.2M
Q1 25
$-2.9M
$-5.0M
Q4 24
$-16.8M
$4.2M
Q3 24
$15.1M
$819.0K
Q2 24
$2.9M
$-15.7M
Free Cash Flow
HNST
HNST
TOI
TOI
Q1 26
Q4 25
$18.1M
$2.2M
Q3 25
$-624.0K
$-13.2M
Q2 25
$-826.0K
$-11.4M
Q1 25
$-3.0M
$-5.3M
Q4 24
$-17.2M
$2.4M
Q3 24
$15.0M
$417.0K
Q2 24
$2.9M
$-17.5M
FCF Margin
HNST
HNST
TOI
TOI
Q1 26
Q4 25
20.5%
1.5%
Q3 25
-0.7%
-9.7%
Q2 25
-0.9%
-9.5%
Q1 25
-3.1%
-5.1%
Q4 24
-17.2%
2.4%
Q3 24
15.1%
0.4%
Q2 24
3.1%
-17.7%
Capex Intensity
HNST
HNST
TOI
TOI
Q1 26
0.6%
Q4 25
1.4%
0.7%
Q3 25
0.1%
0.4%
Q2 25
0.1%
1.0%
Q1 25
0.1%
0.3%
Q4 24
0.3%
1.8%
Q3 24
0.1%
0.4%
Q2 24
0.0%
1.9%
Cash Conversion
HNST
HNST
TOI
TOI
Q1 26
Q4 25
Q3 25
-0.66×
Q2 25
-0.19×
Q1 25
-0.90×
Q4 24
Q3 24
91.42×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HNST
HNST

Segment breakdown not available.

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons